Most people do not recognize cancer warning signs
the ONA take:
According to a new study published in the journal PLOS ONE, most people ignore cancer "alarm" symptoms. Researchers at University College London in London, United Kingdom, asked 1,724 participants aged 50 years and over whether they had experienced and of 17 cancer "alarm" symptoms.
Some symptoms included in the questionnaire were changes in mole appearance, difficulty swallowing, persistent change in bowel habits, unexplained bleeding, unexplained cough, unexplained lumps, and unexplained weight loss. Participants were not informed as to which symptoms are warning signs of cancer.
They were asked what they the thought to be the cause of any symptoms they experienced, as well as how serious they deemed the symptoms to be and if they visited the doctor as a result.
Of all respondents of the questionnaire, 53% reported experiencing at least one cancer warning symptom in the last 3 months and only 2% considered the warning symptoms to be cancer-related. Persistent cough and persistent change in bowel habits were the most common cancer warning signs experienced; unexplained weight loss and difficulty swallowing were the least.
Results showed that 59% of participants who experienced cancer signs visited a doctor. The findings suggest that many people who experience cancer signs do not realize the seriousness of their symptoms.
Most people ignore cancer "alarm" symptoms.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|